Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.

Journal:

Journal of Clinical Oncology

Published:

2026-02-05

DOI:

10.1200/jco-25-00834

Affiliations:

7

Authors:

10

Go to article

Institutions	Authors	Share
Manchester Centre for Genomic Medicine (MCGM), United Kingdom (UK)	3.000000	0.30
The University of Manchester (UoM), United Kingdom (UK)	2.333333	0.23
Manchester University NHS Foundation Trust (MFT), United Kingdom (UK)	2.333333	0.23
Manchester Academic Health Science Centre (MAHSC), United Kingdom (UK)	1.333333	0.13
The Christie NHS Foundation Trust, United Kingdom (UK)	1.000000	0.10

Interested in Oncology and Carcinogenesis?